14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today EDGE ranks #14713 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Edge Therapeutics Stock Forecast NASDAQ:EDGE

$9.25 (9.86%)

Volume: 346k

Closed: Dec 07, 2021

Hollow Logo Score: -3.120

Edge Therapeutics Stock Forecast

$9.25 (9.86%)

Volume: 346k

Closed: Dec 07, 2021

Score Hollow Logo -3.120
Which way will EDGE go? Request

EDGE Stock Risk

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.87 between high and low, or 10.13%. For the last week, the stock has had a daily average volatility of 10.80%.

Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 38 and the stock is currently not being overbought or oversold

High volatility in Edge Therapeutics stock price on Tuesday which ended trading at $9.25
(Updated on Dec 07, 2021)


Sell candidate since 2021-11-15 Loss -15.22%

The Edge Therapeutics stock price gained 9.86% on the last trading day (Tuesday, 7th Dec 2021), rising from $8.42 to $9.25. During the day the stock fluctuated 10.13% from a day low at $8.59 to a day high of $9.46. The price has risen in 6 of the last 10 days, but is still down by -0.96% for this period. Volume fell on the last day by -353 thousand shares and in total, 346 thousand shares were bought and sold for approximately $3.20 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -40.43% during the next 3 months and, with a 90% probability hold a price between $4.88 and $6.52 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

There are mixed signals in the stock today. The Edge Therapeutics stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $10.76. On a fall, the stock will find some support from the short-term average at $9.07. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Friday, December 03, 2021, and so far it has risen 9.86%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss

Edge Therapeutics finds support from accumulated volume at $9.10 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.87 between high and low, or 10.13%. For the last week, the stock has had a daily average volatility of 10.80%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Edge Therapeutics stock A Buy?

Edge Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.120

Predicted Opening Price for Edge Therapeutics of Wednesday, December 8, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 8, 2021 Current price
$9.10 $9.25 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Volatility and Risk
Daily Average Volatility: 10.80 %
Overall Risk: Very High High Medium Low Very Low
Volatility
10.80 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $9.34
Price: $9.25
Support: $9.10

EDGE Insider Trading Show all Trades

INSIDER POWER

10.392

Last 100 transactions
Buy: 5 043 149 | Sell: 485 273 (Shares)
Date Action Amount Person Type
Jan 04, 2021 Buy 202 800 Van Voorhees Seth Stock Option (Right to Buy)
Dec 08, 2020 Buy 210 500 Wood Lauren Stock Option (Right to Buy)
Dec 08, 2020 Buy 122 400 Conn Gregory Stock Option (Right to Buy)
Dec 08, 2020 Buy 707 800 Bedu-addo Frank Stock Option (Right to Buy)
Dec 08, 2020 Buy 50 000 King Michael N. Stock Option (Right to Buy)
Show all Insider Trades
INSIDER POWER

10.392

Last 100 transactions
Buy: 5 043 149 | Sell: 485 273 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 9.97 7.78 %
9.64 4.19 %
9.43 1.97 %
Current price: 9.25
Support 8.77 -5.21 %
8.56 -7.43 %
8.23 -11.03 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 11.46 23.89 %
10.20 10.27 %
9.34 0.97 %
Current price 9.25
Support 9.10 -1.62%
8.99 -2.81%
8.42 -8.97%

Click to get the best stock tips daily for free!

About Edge Therapeutics

Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT